Prescription Omega-3-acid Ethyl Esters Reduce Fasting And Postprandial Triglycerides And Modestly Reduce Pancreatic β-cell Response In Subjects With Primary Hypertriglyceridemia
Notes for this study:
|Number of Subjects
In hyperlipidemic patients given 4g of EPA ethyl ester daily for 14 weeks, the main study parameter (increase in glucose) trended to increase but failed to reach significance. No measured parameter except triglycerides reached significance, and it was noted triglycerides were reduced by 24.4% (fasting) and 26.3% (postprandial).